Immunogenic and structural properties of the Asn-Gly-Arg (NGR) tumor neovasculature-homing motif
- 7 December 2005
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 43 (10) , 1509-1518
- https://doi.org/10.1016/j.molimm.2005.10.009
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Targeted Delivery of IFNγ to Tumor Vessels Uncouples Antitumor from Counterregulatory MechanismsCancer Research, 2005
- Tumor Vascular Targeting with Tumor Necrosis Factor α and Chemotherapeutic DrugsAnnals of the New York Academy of Sciences, 2004
- Structure-Activity Relationships of Linear and Cyclic Peptides Containing the NGR Tumor-homing MotifJournal of Biological Chemistry, 2002
- Strategies for vascular targeting in tumorsInternational Journal of Cancer, 2002
- Steps toward mapping the human vasculature by phage displayNature Medicine, 2002
- Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)Nature Biotechnology, 2000
- Antibody humanization: a case of the ‘Emperor’s new clothes’?Immunology Today, 2000
- Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse ModelScience, 1998
- Vascular targeting—a new approach to the therapy of solid tumorsPharmacology & Therapeutics, 1994
- Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells.Proceedings of the National Academy of Sciences, 1988